. . . . . . . "[The aim of the mutation (IL13.E13K.R109K) was to enhance selectivity of the CAR for recognition and killing of IL13R?2(+) GBMs while sparing normal cells bearing the composite IL13R?1/IL4R? receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:56+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .